(0.30%) 5 170.25 points
(0.25%) 38 930 points
(0.27%) 18 049 points
(1.11%) $78.98
(0.42%) $2.15
(0.84%) $2 328.00
(2.61%) $27.39
(0.82%) $973.20
(-0.03%) $0.929
(-0.28%) $10.84
(-0.20%) $0.795
(-0.01%) $91.44
4 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
-0.74% ¥ 5 380.00
Live Chart Being Loaded With Signals
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household...
Stats | |
---|---|
Tagesvolumen | 1.29M |
Durchschnittsvolumen | 3.00M |
Marktkapitalisierung | 399.94B |
EPS | ¥0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( ¥54.40 ) 2024-05-10 |
Last Dividend | ¥39.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 20.08 |
ATR14 | ¥3.69 (0.07%) |
Volumen Korrelation
Kobayashi Pharmaceutical Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Kobayashi Pharmaceutical Korrelation - Währung/Rohstoff
Kobayashi Pharmaceutical Finanzdaten
Annual | 2023 |
Umsatz: | ¥173.46B |
Bruttogewinn: | ¥93.17B (53.72 %) |
EPS: | ¥268.16 |
FY | 2023 |
Umsatz: | ¥173.46B |
Bruttogewinn: | ¥93.17B (53.72 %) |
EPS: | ¥268.16 |
FY | 2022 |
Umsatz: | ¥166.26B |
Bruttogewinn: | ¥92.33B (55.53 %) |
EPS: | ¥259.61 |
FY | 2021 |
Umsatz: | ¥155.25B |
Bruttogewinn: | ¥88.77B (57.18 %) |
EPS: | ¥187.94 |
Financial Reports:
No articles found.
Kobayashi Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥52.00 (N/A) |
¥0 (N/A) |
¥39.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.667 | 2001-03-27 |
Last Dividend | ¥39.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 41 | -- |
Total Paid Out | ¥957.83 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.48 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.23 | |
Div. Directional Score | 6.90 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
7956.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
7187.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6432.T | Ex Dividend Junior | 2024-02-28 | Annually | 0 | 0.00% | |
5411.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
4433.T | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
3612.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
2818.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
1446.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9274.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
8267.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.117 | 1.500 | 7.65 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0760 | 1.200 | 7.47 | 8.96 | [0 - 0.3] |
returnOnEquityTTM | 0.0984 | 1.500 | -0.0179 | -0.0268 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.82 | 0.800 | 0.891 | 0.713 | [1 - 3] |
quickRatioTTM | 2.37 | 0.800 | 0.782 | 0.625 | [0.8 - 2.5] |
cashRatioTTM | 1.275 | 1.500 | 4.03 | 6.04 | [0.2 - 2] |
debtRatioTTM | 0.00369 | -1.500 | 9.94 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 921.00 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00482 | -1.500 | 9.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.545 | 1.000 | 4.24 | 4.24 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.154 | 1.000 | 8.92 | 8.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 12.27 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.648 | 0.800 | 9.01 | 7.21 | [0.5 - 2] |
Total Score | 10.57 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 19.85 | 1.000 | 8.10 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0984 | 2.50 | -0.0115 | -0.0268 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.877 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 161.45 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0698 | 1.000 | -0.754 | 0 | [0.1 - 0.5] |
Total Score | 3.23 |
Kobayashi Pharmaceutical
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.